#pfizer (2 Posts)
-
Pfizer Ends Obesity Drug Trial After Liver Risk Emerges Pfizer halts development of danuglipron for obesity treatment due to liver injury concerns despite exploring various dosages. -
Pfizer to Sell $2.5 Billion Worth of Haleon Shares, Focusing on Pharmaceutical Innovation Pfizer has started to dispose of its stake in Haleon, as it previously expressed its desire to focus on pharmaceutical innovation. Pfizer plans to sell about 2 billion pounds ($2.5 billion) of Haleon stock, which is the first step in reducing the 32% stake held by Haleon’s largest shareholder. Pfizer has been stating for a […]
Hot Topics